Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 14 November 2022 – On 4 November 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period beginning 2 February 2022.
Under the programme initiated 4 November 2022, Novo Nordisk will repurchase B shares for an amount up to DKK 3.8 billion in the period from 7 November 2022 to 30 January 2023.
Since the announcement of the programme, the following transactions have been made:
| Number of B shares | Average purchase price | Transaction value, DKK | |
| 7 November 2022 | 83,000 | 845.76 | 70,198,440 |
| 8 November 2022 | 84,000 | 851.04 | 71,487,335 |
| 9 November 2022 | 83,985 | 846.69 | 71,109,025 |
| 10 November 2022 | 84,000 | 849.47 | 71,355,458 |
| 11 November 2022 | 90,000 | 821.58 | 73,942,629 |
| Accumulated under the programme | 424,985 | 358,092,886 |
The details for each transaction made under the share repurchase programme are published on novonordisk.com.
Transactions related to Novo Nordisk’s incentive programmes have resulted in a net transfer from Novo Nordisk of 14,324 B shares in the period from 7 November 2022 to 11 November 2022. The shares in these transactions were not part of the Safe Harbour repurchase programme.
With the transactions stated above, Novo Nordisk owns a total of 27,853,803 B shares of DKK 0.20 as treasury shares, corresponding to 1.2% of the share capital. The total amount of A and B shares in the company is 2,280,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 24 billion during a 12-month period beginning 2 February 2022. As of 11 November 2022, Novo Nordisk has since 2 February 2022 repurchased a total of 26,164,617 B shares at an average share price of DKK 785.09 per B share equal to a transaction value of DKK 20,541,494,941
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 53,000 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com,Facebook, Twitter, LinkedIn andYouTube.
Contact for further information
| Media: | |
| Ambre Brown Morley +45 3079 9289 abmo@novonordisk.com | Natalia Salomao Abrahao (US) +1 848 304 1027 niaa@novonordisk.com |
| Investors: | |
| Daniel Muusmann Bohsen +45 3075 2175 dabo@novonordisk.com | Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com |
| David Heiberg Landsted +45 3077 6915 dhel@novonordisk.com | Mark Joseph Root (US) +1 848 213 3219 mjhr@novonordisk.com |
Company announcement No 84 /2022
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Photocat call for General assembly 22nd May 2024 at 16:006.5.2024 17:00:00 CEST | Press release
Photocat A/S Annual General meeting 2024 The Board of Photocat A/S, Danish CVR No 32 35 79 03 (the “Company”) hereby convenes an annual general meeting to be held 22nd May 2024 at 16.00 CET at Photocat A/S, Langebjerg 4, 4000 Roskilde or by Zoom as a virtual meeting Agenda In accordance with Article of Association, 9.2 1.The Board’s report on the activities of the Company 2. Presentation of the annual report for adaptation 3. Resolution on the appropriation of profit or covering of loss pursuant to the adopted annual report 4. Election of members for the Board of Directors 5. Appointment of auditor 6. Any other business Re 1. The Board’s report on the activities of the Company The report of the Board on the business of the Company during the most recent financial year. Re 2. Presentation of the annual report for adaptation The Board recommends that the presented annual report be adopted. Re 3 Resolution on the appropriation of profit or covering of loss pursuant to the adopted annual r
NORBIT ASA – Minutes from NORBIT ASA's Annual General Meeting 20246.5.2024 16:54:13 CEST | Press release
Trondheim, 6 May 2024: The annual general meeting of NORBIT ASA was held today, 6 May 2024. All proposals on the agenda were approved by the general meeting, including the board's proposed dividend distribution of NOK 2.55 per share. The dividend will be paid on or about 16 May 2024 to the shareholders of NORBIT ASA as of 6 May 2024. The shares will trade exclusive the right to receive dividend from and including 7 May 2024. The chair of the board, Finn Haugan, directors Magnus Reitan and Christina Hallin, as well as deputy director Tom Solberg were elected for terms which expire this year. Finn Haugan and Christina Hallin were re-elected in their positions for a period of two years. Håkon Kavli was elected as a new director for two years, replacing Magnus Reitan. Tom Solberg was re-elected as deputy director to the board for a period of one year. Following these elections, the board has the following composition: Finn Haugan (Chair, re-elected for two years) Bente Avnung Landsnes (Dep
Afarak Group: Production report Q1 20246.5.2024 16:30:44 CEST | Press release
15:30 London, 17:30 Helsinki, May 06 2024 - Afarak Group SE (“Afarak” or “the Company”) (LSE: AFRK, NASDAQ: AFAGR) Production report Q1 2024 Afarak Group production during the first quarter of 2024 was higher by 9.7% when compared to same period of last year. Q1/2024Q1/2023ChangeFY 2023Speciality Alloys mt23,41124,359-3.9%86,834Processingmt6,9017,581-9.0%21,179Miningmt16,51016,778-1.6%65,655South African minesmt70,27861,045 15.1%270,946Miningmt70,27861,04515.1%270,946 Processing The processing volumes decreased by 9.0% during the first quarter of 2024 when compared to the first quarter of 2023. This was due to a maintenance which had to be carried out due to a minor technical issue. Mining The overall mining activity increased significantly when compared to same period of last year mainly due to an increase in the tonnes mined in South Africa. The output increased in South Africa due to the continued favourable prices in the Ore market.Mining activity at the Turkish mines remained cons
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities6.5.2024 16:17:33 CEST | Press release
Today, primary insider Dag Arthur Aasbø, Senior Vice President (SVP), exercised 15,000 stock options at a strike price of NOK 87.60 per share and in separate transactions, purchased and sold the same number of shares. The shares are drawn from Borregaard’s holdings of treasury shares. Please, see attached notifications for persons discharging managerial responsibilities in Borregaard in accordance with Regulation EU 596/2014 (MAR) article 19. After the transactions, Dag Arthur Aasbø owns 56,254 shares and holds 34,500 stock options in Borregaard. Today, primary insider Per Bjarne Lyngstad, Chief Financial Officer (CFO), exercised 20,000 stock options at a strike price of NOK 87.60 per share and in separate transactions, purchased and sold the same number of shares. The shares are drawn from Borregaard’s holdings of treasury shares. Please, see attached notifications for persons discharging managerial responsibilities in Borregaard in accordance with Regulation EU 596/2014 (MAR) article
Park Street A/S - Share buyback program 20246.5.2024 16:15:53 CEST | Press release
Park Street A/S – Share buyback program 2024 Transactions during 23 April 2024 - 06 May 2024 On 28th February 2024, Park Street A/S announced a share buy-back program, as described in Company Announcement dated 28-02-2024. The program is carried out in compliance with the provisions of Regulation No 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation – MAR) and delegated legislation under MAR; except for the limitation of implementing the authorized buy-back of the Company’s shares within the 25% daily trading volume, due to the low levels of market liquidity in the Company’s shares. According to the program, Park Street A/S will repurchase Class A and Class B shares for up to DKK 100 million. The program takes place during the period from 28 February 2024 – 30 June 2024. The following transactions were made under the share buy-back program during 23 April 2024 - 06 May 2024: Number of shares bought Average transaction priceAccumulated, l